CASM Financial Facts
Research and development: 849.55KNet sales: 5.76M
See Full Income Statement
Accounts receivable, net of allowance: 3.25M
Property and equipment, gross: 8.77M
See Full Balance Sheet
CAS Medical Systems (CASM) Earnings
|
Expand Research on CASM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +4,181.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/17 |  |
Q317 | $10.00 | -$0.06 | +$10.06 | $4.5M | $5.88M | = |  | | Details |
| 8/4/16 | Q216 | -$0.08 | -$0.05 | -$0.03 | $5.5M | $5.58M | N/A | | | Details | |
| 3/9/16 | Q415 | -$0.08 | N/A | N/A | $5.8M | $5.2M | N/A | | | Details | |
11/5/15  |
|
Q315 | -$0.08 | -$0.09 | +$0.01 | $5.5M | $5.66M | N/A | | | Details |
| 8/5/15 |
|
Q215 | -$0.09 | -$0.10 | +$0.01 | $5.8M | $5.36M | N/A | | | Details |
| 5/5/15 |
|
Q115 | -$0.08 | -$0.10 | +$0.02 | $5.8M | $5.21M | N/A | | | Details |
| 3/4/15 |
|
Q414 | -$0.11 | -$0.11 | $0.00 | $5.8M | $5.8M | N/A | | | Details |
| 8/6/14 | Q214 | -$0.13 | -$0.11 | -$0.02 | $5.8M | $5M | N/A | | | Details |
